Cargando…
Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population
We set out to evaluate the performance of a multitarget stool DNA (MT-sDNA) in an average-risk colonoscopy-controlled colorectal cancer (CRC) screening population. MT-sDNA stool test results were evaluated against fecal immunochemical test (FIT) results for the detection of different lesions, includ...
Autores principales: | Bosch, L.J.W., Melotte, V., Mongera, S., Daenen, K.L.J., Coupé, V.M.H., van Turenhout, S.T., Stoop, E.M., de Wijkerslooth, T.R., Mulder, C.J.J., Rausch, C., Kuipers, E.J., Dekker, E., Domanico, M.J., Lidgard, G.P., Berger, B.M., van Engeland, M., Carvalho, B., Meijer, G.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903367/ https://www.ncbi.nlm.nih.gov/pubmed/31764091 http://dx.doi.org/10.14309/ajg.0000000000000445 |
Ejemplares similares
-
Face-to-face vs telephone pre-colonoscopy consultation in colorectal cancer screening; a randomised trial
por: Stoop, E M, et al.
Publicado: (2012) -
Smoking status informs about the risk of advanced serrated polyps in a screening population
por: IJspeert, J. E. G., et al.
Publicado: (2016) -
Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of Medicare beneficiaries
por: Naber, Steffie K., et al.
Publicado: (2019) -
Scenario drafting for early technology assessment of next generation sequencing in clinical oncology
por: Joosten, S.E.P., et al.
Publicado: (2016) -
Proteins in stool as biomarkers for non‐invasive detection of colorectal adenomas with high risk of progression
por: Komor, Malgorzata A, et al.
Publicado: (2020)